Decisions of Herantis Pharma Plc’s Annual General Meeting of shareholders
Herantis Pharma Plc Company release, 20 April 2023 at 1:35 p.m. Eastern European Summer Time Herantis Pharma Plc's (“Herantis”) Annual General Meeting was held in Helsinki on Thursday, 20 April 2023. The Annual General Meeting decided upon the following: Adoption of the annual accounts The Annual General Meeting adopted the consolidated financial statements and the parent company’s financial statements for the financial year 1 January – 31 December 2022. Profit / loss for the financial year The Annual General Meeting resolved, in accordance with the proposal by the Board